Ascendis Pharma AS (A71) — Cash Flow Reinvestment Rate
Ascendis Pharma AS (A71) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €3.39 Million (capex €3.39 Million ) from operating cash flow of €73.40 Million. Check Ascendis Pharma AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ascendis Pharma AS Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Ascendis Pharma AS across 1 annual periods. Explore A71 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Ascendis Pharma AS (2025–2025)
Year-by-year capital reinvestment analysis for Ascendis Pharma AS. For live market cap and broader valuation context, see A71 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.16x | €8.48 Million | €53.90 Million | €8.48 Million | — |